François Bertucci (Francois Bertucci)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 64

Top Topics

Early Breast Cancer

Tyrosine Kinase

Sentinel Lymph Node

Top Venues

Science advances

NPJ breast cancer

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Gayathri R Devi, Pritha Pai, Seayoung Lee, Matthew W Foster, Dorababu S Sannareddy, François Bertucci, Naoto Ueno, Steven J Van Laere
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer. NPJ breast cancer 10 (1) (2024)
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti, José Adélaïde, Steven Van Laere, Anthony Goncalves, Patrice Viens, Daniel Birnbaum, Emilie Mamessier, Céline Callens, Davide Bedognetti
Mutational landscape of inflammatory breast cancer. Journal of translational medicine 22 (1) (2024)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy. Cancer research communications 4 (1) (2024)
Yi-Zhou Jiang, Ding Ma, Xi Jin, Yi Xiao, Ying Yu, Jinxiu Shi, Yi-Fan Zhou, Tong Fu, Cai-Jin Lin, Lei-Jie Dai, Cheng-Lin Liu, Shen Zhao, Guan-Hua Su, Wanwan Hou, Ya-Qing Liu, Qing-Wang Chen, Jingcheng Yang, Naixin Zhang, Wen-Juan Zhang, Wei Liu, Weigang Ge, Wen-Tao Yang, Chao You, Yajia Gu, Virginia Kaklamani, François Bertucci, Claire Verschraegen, Anneleen Daemen, Nakul M Shah, Ting Wang, Tiannan Guo, Le-Ming Shi, Charles M Perou, Yuanting Zheng, Wei Huang, Zhi-Ming Shao
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities. Nature cancer 5 (4) (2024)
Alexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, Arnaud Guille, José Adelaïde, Pascal Finetti, Maria Cappiello, Eric Lambaudie, Giuseppe Ettore, Emmanuelle Charafe, Emilie Mamessier, Magali Provansal, François Bertucci, Renaud Sabatier
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization. Molecular oncology (2024)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy. Cancer research communications 4 (1) (2024)
Gayathri R Devi, Pritha Pai, Seayoung Lee, Matthew W Foster, Dorababu S Sannareddy, François Bertucci, Naoto Ueno, Steven J Van Laere
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer. NPJ breast cancer 10 (1) (2024)
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti, José Adélaïde, Steven Van Laere, Anthony Goncalves, Patrice Viens, Daniel Birnbaum, Emilie Mamessier, Céline Callens, Davide Bedognetti
Mutational landscape of inflammatory breast cancer. Journal of translational medicine 22 (1) (2024)
Gayathri R Devi, Pritha Pai, Seayoung Lee, Matthew W Foster, Dorababu S Sannareddy, François Bertucci, Naoto Ueno, Steven J Van Laere
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer. NPJ breast cancer 10 (1) (2024)
Yi-Zhou Jiang, Ding Ma, Xi Jin, Yi Xiao, Ying Yu, Jinxiu Shi, Yi-Fan Zhou, Tong Fu, Cai-Jin Lin, Lei-Jie Dai, Cheng-Lin Liu, Shen Zhao, Guan-Hua Su, Wanwan Hou, Ya-Qing Liu, Qing-Wang Chen, Jingcheng Yang, Naixin Zhang, Wen-Juan Zhang, Wei Liu, Weigang Ge, Wen-Tao Yang, Chao You, Yajia Gu, Virginia Kaklamani, François Bertucci, Claire Verschraegen, Anneleen Daemen, Nakul M Shah, Ting Wang, Tiannan Guo, Le-Ming Shi, Charles M Perou, Yuanting Zheng, Wei Huang, Zhi-Ming Shao
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities. Nature cancer 5 (4) (2024)
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti, José Adélaïde, Steven Van Laere, Anthony Goncalves, Patrice Viens, Daniel Birnbaum, Emilie Mamessier, Céline Callens, Davide Bedognetti
Mutational landscape of inflammatory breast cancer. Journal of translational medicine 22 (1) (2024)
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti, José Adélaïde, Steven Van Laere, Anthony Goncalves, Patrice Viens, Daniel Birnbaum, Emilie Mamessier, Céline Callens, Davide Bedognetti
Mutational landscape of inflammatory breast cancer. Journal of translational medicine 22 (1) (2024)
Yi-Zhou Jiang, Ding Ma, Xi Jin, Yi Xiao, Ying Yu, Jinxiu Shi, Yi-Fan Zhou, Tong Fu, Cai-Jin Lin, Lei-Jie Dai, Cheng-Lin Liu, Shen Zhao, Guan-Hua Su, Wanwan Hou, Ya-Qing Liu, Qing-Wang Chen, Jingcheng Yang, Naixin Zhang, Wen-Juan Zhang, Wei Liu, Weigang Ge, Wen-Tao Yang, Chao You, Yajia Gu, Virginia Kaklamani, François Bertucci, Claire Verschraegen, Anneleen Daemen, Nakul M Shah, Ting Wang, Tiannan Guo, Le-Ming Shi, Charles M Perou, Yuanting Zheng, Wei Huang, Zhi-Ming Shao
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities. Nature cancer (2024)
Alexandre Bertucci, François Bertucci, Anthony Goncalves
Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements. Cancers 15 (5) (2023)
Sandra Udu-Ituma, José Adélaïde, Thi Khanh Le, Kenneth Omabe, Pascal Finetti, Clément Paris, Arnaud Guille, François Bertucci, Daniel Birnbaum, Palma Rocchi, Max Chaffanet
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. Pharmaceutics 15 (7) (2023)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications (2023)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications (2023)
Olivier Trédan, Maud Toulmonde, Christophe Le Tourneau, Laure Montane, Antoine Italiano, Isabelle L Ray-Coquard, Christelle De La Fouchardière, François Bertucci, Anthony Goncalves, Carlos Gomez-Roca, Benoit You, Valéry Attignon, Sandrine Boyault, Philippe A Cassier, Armelle Dufresne, Séverine Tabone-Eglinger, Alain Viari, Emilie Sohier, Maud Kamal, Gwenaël Garin, Jean Yves Blay, David Pérol
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort. Cancers 15 (13) (2023)
David Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, Thomas Delayre, Pascal Finetti, Olivier Cabaud, Emilie Agavnian, Bernadette De Rauglaudre, Emilie Denicolaï, François Bertucci, Emilie Mamessier
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers 15 (2) (2023)
Stéphane Fattori, Aude Le Roy, Jemila Houacine, Lucie Robert, Riad Abes, Laurent Gorvel, Samuel Granjeaud, Marie-Sarah Rouvière, Amira Ben Amara, Nicolas Boucherit, Carole Tarpin, Jihane Pakradouni, Emmanuelle Charafe-Jauffret, Gilles Houvenaeghel, Eric Lambaudie, François Bertucci, Philippe Rochigneux, Anthony Goncalves, Arnaud Foussat, Anne-Sophie Chretien, Daniel Olive
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. Cancer research (2023)
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics 15 (3) (2023)
Alice Mogenet, Pascal Finetti, Emilie Denicolai, Laurent Greillier, Pascaline Boudou-Rouquette, François Goldwasser, Gwenael Lumet, Michele Ceccarelli, Daniel Birnbaum, Davide Bedognetti, Emilie Mamessier, Fabrice Barlesi, François Bertucci, Pascale Tomasini
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer. Journal of translational medicine 21 (1) (2023)
David Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, Thomas Delayre, Pascal Finetti, Olivier Cabaud, Emilie Agavnian, Bernadette De Rauglaudre, Emilie Denicolaï, François Bertucci, Emilie Mamessier
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers 15 (2) (2023)
François Bertucci, Pascal Finetti, Emilie Mamessier, Alexandre De Nonneville
The MonarchE trial: improving the clinical outcome in HR + /HER2 - early breast cancer: recent results and next steps. Cancer communications (London, England) (2023)
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics 15 (3) (2023)
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics 15 (3) (2023)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications (2023)
Nicolas Penel, Sylvie Bonvalot, Marie-Cécile Le Deley, Antoine Italiano, Camille Tlemsani, Diane Pannier, Clémence Leguillette, Jean-Emmanuel Kurtz, Maud Toulmonde, Julien Thery, Daniel Orbach, Pascale Dubray-Longeras, Benjamin Verret, François Bertucci, Cécile Guillemet, Lucie Laroche, Armelle Dufresne, Jean Yves Blay, Axel Le Cesne
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value. International journal of cancer (2023)
François Bertucci, Alexandre De Nonneville, Pascal Finetti, Emilie Mamessier
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer. Cancer communications (London, England) (2023)
Alexandre Bertucci, François Bertucci, Anthony Goncalves
Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements. Cancers 15 (5) (2023)
Florence Duffaud, Jean Yves Blay, Axel Le Cesne, Christine Chevreau, Pascaline Boudou-Rouquette, Elsa Kalbacher, Nicolas Penel, Christophe Perrin, Valérie Laurence, Emmanuelle Bompas, Esma Saada-Bouzid, Corinne Delcambre, François Bertucci, Mathilde Cancel, Camille Schiffler, Laure Monard, Corinne Bouvier, Vincent Vidal, Nathalie Gaspar, Sylvie Chabaud
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study. British journal of cancer (2023)
Yohan Fayet, Christine Chevreau, Gauthier Decanter, Cécile Dalban, Pierre Meeus, Sébastien Carrère, Leila Haddag-Miliani, François Le Loarer, Sylvain Causeret, Daniel Orbach, Michelle Kind, Louis-Romée Le Nail, Gwenaël Ferron, Hélène Labrosse, Loïc Chaigneau, François Bertucci, Jean-Christophe Ruzic, Valérie Le Brun Ly, Fadila Farsi, Emmanuelle Bompas, Sabine Noal, Aurore Vozy, Agnes Ducoulombier, Clément Bonnet, Sylvie Chabaud, Francoise Ducimetiere, Camille Tlemsani, Mickaël Ropars, Olivier Collard, Paul Michelin, Justine Gantzer, Pascale Dubray-Longeras, Maria Rios, Pauline Soibinet, Axel Le Cesne, Florence Duffaud, Marie Karanian, François Gouin, Raphaël Tétreau, Charles Honoré, Jean-Michel Coindre, Isabelle L Ray-Coquard, Sylvie Bonvalot, Jean Yves Blay
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome? Cancers 14 (11) (2022)
Olivier Cabaud, Ludovic Berger, Emerence Crompot, José Adélaide, Pascal Finetti, Sèverine Garnier, Arnaud Guille, Nadine Carbuccia, Anne Farina, Emilie Agavnian, Max Chaffanet, Anthony Goncalves, Emmanuelle Charafe-Jauffret, Emilie Mamessier, Daniel Birnbaum, François Bertucci, Marc Lopez
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate. Molecular cancer therapeutics 21 (7) (2022)
Laurys Boudin, A de Nonneville, Pascal Finetti, Léna Mescam, A Le Cesne, Antoine Italiano, Jean-Yves Blay, Daniel Birnbaum, Emilie Mamessier, François Bertucci
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response. Journal of translational medicine 20 (1) (2022)
Emilien Billon, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle, Jeanne Thomassin-Piana, Géraldine Pignot, Jochen Walz, Christian Chabanon, Jihane Pakradouni, Renaud Sabatier, Cécile Vicier, Cornel Popovici, Emilie Mamessier, Anthony Goncalves, Daniel Birnbaum, Max Chaffanet, François Bertucci
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial. Cancers 14 (9) (2022)
Maroua Manai, Ines ELBini-Dhouib, Pascal Finetti, Haifa Bichiou, Giancarlo Feliciello, Dorra Aissaoui, Naziha Ben-Hamida, Emilie Agavnian, Najet Srairi-Abid, Marc Lopez, Fatma Amri, Lamia Guizani-Tabbane, Khaled Rahal, Karima Mrad, Mohamed Manai, Daniel Birnbaum, Emilie Mamessier, Massimo Cristofanilli, Hamouda Boussen, Maher Kharrat, Raoudha Doghri, François Bertucci
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. Cells 11 (18) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Alexandre de Nonneville, Sebastien Salas, François Bertucci, Alexander P Sobinoff, José Adélaïde, Arnaud Guille, Pascal Finetti, Jane R Noble, Dimitri Churikov, Max Chaffanet, Elise Lavit, Hilda A Pickett, Corinne Bouvier, Daniel Birnbaum, Roger R Reddel, Vincent Geli
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. EMBO molecular medicine 14 (10) (2022)
Mathias Neron, Arnaud Guille, Lucie Allegre, Pierre-Emmanuel Colombo, Cristina Leaha, José Adelaide, Nadine Carbuccia, Frédéric Courtier, Florence Boissière, Evelyne Lopez-Crapez, Michel Fabbro, Sébastien Gouy, Emilie Mamessier, Éric Lambaudie, Daniel Birnbaum, François Bertucci, Max Chaffanet
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of personalized medicine 12 (5) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Véronique Rigot, Julie Leca, Sarah-Simha Tubiana, Pascal Finetti, Fabienne Guillaumond, Sebastien Martinez, Sophie Lac, Juan L Iovanna, Stephane Audebert, Luc Camoin, Sophie Vasseur, François Bertucci, Richard Tomasini
CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness. Science signaling 15 (745) (2022)
Charlotte Rypens, François Bertucci, Pascal Finetti, Fredika Robertson, Sandra V Fernandez, Naoto Tada Ueno, Wendy A Woodward, Kenneth Van Golen, Peter Vermeulen, Luc Dirix, Patrice Viens, Daniel Birnbaum, Gayathri R Devi, Massimo Cristofanilli, Steven Van Laere
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. NPJ breast cancer 8 (1) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Alexia Mélanie Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, Anaïs Aulas, Maria Lucia Liberatoscioli, Olivier Cabaud, Arnaud Guille, Alexandre de Nonneville, Quentin Da Costa, Emilie Denicolai, Jihane Pakradouni, Anthony Goncalves, Daniel Birnbaum, François Bertucci, Emilie Mamessier
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. Cancers 14 (4) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Justine Gantzer, Guillaume Davidson, Bujamin Vokshi, Noëlle Weingertner, Antoine Bougoüin, Marco Moreira, Véronique Lindner, Guillaume Lacroix, Céline Mascaux, Marie-Pierre Chenard, François Bertucci, Irwin Davidson, Jean-Emmanuel Kurtz, Catherine Sautès-Fridman, Wolf H Fridman, Gabriel G Malouf
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors. The oncologist 27 (6) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Alexandre de Nonneville, Pascal Finetti, Emilie Mamessier, François Bertucci
RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. Journal of the National Cancer Institute 114 (7) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Alban Macagno, Alexandre de Nonneville, Pierre Annede, Gilles Piana, Isabelle Pougnet, Nassima Daidj, Laurence Moureau-Zabotto, Julien Darreon, Laetitia Padovani, François Bertucci, Naji Salem
Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease. Current oncology (Toronto, Ont.) 29 (3) (2022)
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier, François Bertucci
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers 14 (5) (2022)
Victoire Gouirand, Tristan Gicquel, Evan C Lien, Emilie Jaune, Quentin Da Costa, Pascal Finetti, Elodie Metay, Camille Duluc, Jared R Mayers, Stephane Audebert, Luc Camoin, Laurence Borge, Marion Rubis, Julie Leca, Véronique Rigot, François Bertucci, Nelson J Dusetti, Juan Lucio Iovanna, Richard Tomasini, Ghislain Bidaut, Fabienne Guillaumond, Matthew G Vander Heiden, Sophie Vasseur
Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. The EMBO journal 41 (9) (2022)
Laurys Boudin, Alexandre de Nonneville, Pascal Finetti, Geoffrey C Guittard, Jacques A Nunès, Daniel Birnbaum, Emilie Mamessier, François Bertucci
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression. Cancers 14 (14) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Bernadette de Rauglaudre, Pascal Finetti, David Jérémie Birnbaum, Marc Lopez, François Bertucci, Emilie Mamessier
First-in-Human, Phase I Study of PCA062 in Solid Tumors-Letter. Molecular cancer therapeutics 21 (11) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guille, Nadine Carbuccia, Nicolas Isambert, Florence Dalenc, Marie Robert, Christelle Levy, Jihane Pakradouni, José Adelaïde, Max Chaffanet, Patrick Sfumato, Emilie Mamessier, François Bertucci, Anthony Goncalves
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular oncology 16 (10) (2022)
Conception Paul, Ruizhi Tang, Ciro Longobardi, Rossano Lattanzio, Thibaut Eguether, Hulya Turali, Julie Bremond, Chloé Maurizy, Monica Gabola, Sophie Poupeau, Andrei Turtoi, Emilie Denicolai, Maria Concetta Cufaro, Magali Svrcek, Philippe Seksik, Vincent Castronovo, Philippe Delvenne, Vincenzo de Laurenzi, Quentin Da Costa, François Bertucci, Bénédicte Lemmers, Damiana Pieragostino, Emilie Mamessier, Carsten Janke, Valérie Pinet, Michael Hahne
Loss of primary cilia promotes inflammation and carcinogenesis. EMBO reports 23 (12) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
François Bertucci, Anthony Gonçalves, Arnaud Guille, José Adelaïde, Séverine Garnier, Nadine Carbuccia, Emilien Billon, Pascal Finetti, Patrick Sfumato, Audrey Monneur, Christophe Pécheux, Martin Khran, Serge Brunelle, Lenaïg Mescam, Jeanne Thomassin-Piana, Flora Poizat, Emmanuelle Charafe-Jauffret, Olivier Turrini, Eric Lambaudie, Magali Provansal, Jean-Marc Extra, Anne Madroszyk, Marine Gilabert, Renaud Sabatier, Cécile Vicier, Emilie Mamessier, Christian Chabannon, Jihane Pakradouni, Patrice Viens, Fabrice André, Gwenaelle Gravis, Cornel Popovici, Daniel Birnbaum, Max Chaffanet
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial. Genome medicine 13 (1) (2021)
Anthony Goncalves, Pascal Finetti, Daniel Birnbaum, François Bertucci
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer. NPJ breast cancer 7 (1) (2021)
Emilly Schlee Villodre, Xiaoding Hu, Richard Larson, Pascal Finetti, Kristen Gomez, Wintana Balema, Shane R Stecklein, Ginette Santiago-Sanchez, Savitri Krishnamurthy, Juhee Song, Xiaoping Su, Naoto T Ueno, Debu Tripathy, Steven Van Laere, François Bertucci, Pablo Vivas-Mejía, Wendy A Woodward, Bisrat G Debeb
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Molecular oncology 15 (10) (2021)
François Bertucci, Charlotte Rypens, Pascal Finetti, Arnaud Guille, José Adélaïde, Audrey Monneur, Nadine Carbuccia, Séverine Garnier, Piet Dirix, Anthony Gonçalves, Peter Vermeulen, Bisrat G Debeb, Xiaoping Wang, Luc Dirix, Naoto T Ueno, Patrice Viens, Massimo Cristofanilli, Max Chaffanet, Daniel Birnbaum, Steven Van Laere
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. Molecular oncology 14 (3) (2020)
François Bertucci, Pascal Finetti, Anthony Goncalves, Daniel Birnbaum
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype. NPJ breast cancer 6 (2020)